Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sumitomo Pharm Focuses on 3 Fields of Drug Discovery
August 30, 2004
- Research Group Calls For Further Promotion of Generics
August 30, 2004
- Lipovas Lowers Stroke Risk by 25%: JAS Meeting
August 30, 2004
- Nichi-iko, Maruko to Form Business Tie-up
August 30, 2004
- TUT to Initiate Entrepreneur Program
August 30, 2004
- Toyobo to Embark on Contract Manufacturing in Earnest
August 30, 2004
- Iryo Proverbs Reveal Japanese Spirit (22)
August 30, 2004
- MBL, OTS Create Joint Venture to Develop Antibody Drugs
August 30, 2004
- Vitamins D3, K2 Are Second Choice Drugs for Steroid-induced Osteoporosis: GL
August 30, 2004
- JPMA to Survey Environment for Clinical Trials in Asia
August 30, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
August 30, 2004
- Pharmacoeconomics Is Important in Dealing with DPC: Dr Sakamaki
August 30, 2004
- Gov't-managed Health Insurance Programs Report 1st Black Figure in 11 Years: SIA
August 30, 2004
- BUSINESS NEWS IN BRIEF
August 30, 2004
- MEDICAL DEVICE NEWS IN BRIEF
August 30, 2004
- WEBSITE NEWS
August 30, 2004
- NEW PRODUCTS
August 30, 2004
- 1st Qtr Business Results －1－
August 30, 2004
- Nippon HEXAL to Consider M&A to Increase Sales to ¥4-5 Bil.
August 30, 2004
- NHO Plans to Improve Domestic Clinical Trials
August 23, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…